Freight audit principles reveal how clinical supply teams can improve visibility, solve root causes, automate wisely, and build stronger, more resilient operations.
- The Future Of Clinical Supply Operations: Automation Without Losing Human Expertise
- AI And Predictive Analytics For Clinical Supply Planning
- AI Is Hungry For Data: Does Cross Country Data Make Trials Better?
- Engaging Commercial Supply Chain Professionals Early In Clinical Supply Selection
- Managing Global Programs Across Multiple Stakeholders
- Managing Inbound Supply Risk With R3M In Clinical Supply Chains
- Export Control Risks Hidden In Clinical Supply Workflows
- The Post-American Supply Chain: Navigating The New Multipolar Clinical Landscape
ON-DEMAND WEBINARS
This webinar demystifies the term “agile,” from an operational perspective, while highlighting the speed and flexibility these systems offer to be able to support complex protocols that require accelerated changes.
With so many moving parts in a clinical trial, why worry about the technology that is supposed to help manage it? In this webinar, explore five actionable and necessary strategies to leverage RTSM to simplify clinical trial operations.
Guido D’Agostino, Head of Global Procurement at Chiesi, and Stefan Dürr, Senior Director of Product Management and Client Delivery at IQVIA IRT, delve into their achievements in sustainability.
This presentation explores practical pharmacy considerations in early-phase clinical trials, offering real-world insights from experienced clinical research pharmacists.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-179973335 budget]( "The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets")
The Crucial Role Of IRT/RTSM In Optimizing Drug Supply BudgetsExpand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.
-
![iStock-136140244-lab-pharma-equipment-process]( "Speed To Market – API Large-Scale Commercial Manufacturing")
Speed To Market – API Large-Scale Commercial ManufacturingLearn how a top 20 US-based pharma company achieved more capacity to meet commercial supply needs in an accelerated timeline followed by pre-approval inspection with the help of a CMO partner.
-
![GettyImages-1344606074 data insights]( "Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics")
Data-Driven Adaptive Trials Enhance Safety, Progress, And EconomicsBy offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
-
![Panademic Related Manufacturing Complications]( "Outsourcers Are Feeling Uneasy About Continuity Of Supply")
Outsourcers Are Feeling Uneasy About Continuity Of SupplyFind out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.
-
![Internet-Medical-Things-iStock-914789708]( "How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers")
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment NumbersExplore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
![Scientist research laboratory pipette GettyImages-487041629]( "Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions")
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And SolutionsExplore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.
-
![Risk-GettyImages-1364371014]( "How Long Is Your RTSM Risk Mitigation List?")
How Long Is Your RTSM Risk Mitigation List?While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
![7 Seven Tips GettyImages-1450702003]( "7 Key Considerations For Designing The Optimal IRT/RTSM")
7 Key Considerations For Designing The Optimal IRT/RTSMSponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.
-
![genetic research, biotechnology, molecular biology, innovation, healthcare solutions-GettyImages-2234236209]( "Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials")
Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical TrialsEvaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.
-
![Medical-Research-laborratory-GettyImages-1354172439]( "Investigational Medicinal Products: Labeling Changes And Their Implications")
Investigational Medicinal Products: Labeling Changes And Their ImplicationsLearn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
